SDP has received research funding from AstraZeneca, Boehringer Ingelheim, Novartis Pharmaceuticals Co., and Merck Sharpe & Dohme, and is a consultant for or has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Laboratoires Servier, Merck Sharp & Dohme, Novartis Pharmaceuticals Co., Novo Nordisk, Sanofi, and Takeda
Once you have a shortlist, evaluate reliability by making a small deposit, trying a few low-stakes rounds, and requesting a modest withdrawal to test timelines
Important: The information above is for educational purposes only
Offices are maintained in Tampa and Saint Petersburg Beach, Florida